Document Detail

Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts.
MedLine Citation:
PMID:  10448309     Owner:  NLM     Status:  MEDLINE    
The antitumour activity of vinflunine, 20',20'-dichloro-3',4'-dihydrovinorelbine, a fluorinated Vinca alkaloid obtained by reaction in superacid media, was evaluated in comparison with vinorelbine against a series of subcutaneously-implanted human tumour xenografts. The tumours studied were established from bladder (BXF1299), pancreas (PAXF546), kidney (RXF944LX), colon (DLD-1, HT-29, TC37), central nervous system (SF-295), small cell lung (NCI-H69) and prostate (PC-3). Vinflunine or vinorelbine was administered as four weekly intraperitoneal treatments, within dose ranges of 5-80 or 0.63-10 mg/kg/injection, respectively. The overall antitumour activity of vinflunine was superior to that of vinorelbine. Vinflunine showed high activity against RXF944LX and NCI-H69 xenografts and moderate activity against PAXF546, PC-3 and TC37 tumours, achieving an overall response of 64%. This contrasts with a 27% response with vinorelbine, which proved only moderately active against RXF944LX and TC37 xenografts. These results confirm and extend our previous report of the broad spectrum of in vivo antitumour activity of vinflunine and reinforce its potential as a valuable addition to current chemotherapeutic agents.
B T Hill; H H Fiebig; W R Waud; M F Poupon; F Colpaert; A Kruczynski
Related Documents :
7647019 - Development of resistance to activated protein c during pregnancy.
5797779 - Fibrinolytic enzyme system and pregnancy.
24200029 - Acceptability and challenges of rapid art initiation among pregnant women in a pilot pr...
22460969 - Premature delivery in hiv-infected women starting protease inhibitor therapy during pre...
7749349 - Somatogenic and lactogenic activity of the recombinant 22 kda isoform of human placenta...
9553949 - Systemic infantile complex i deficiency with fatal outcome in two brothers.
8986529 - Chorionic villi or trophoblastic tissue in uterine samples of four women with ectopic p...
23876079 - Local illness concepts and their relevance for the prevention and control of malaria du...
7551379 - Postnatal lung function in lambs after fetal hormone treatment. effects of gestational ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of cancer (Oxford, England : 1990)     Volume:  35     ISSN:  0959-8049     ISO Abbreviation:  Eur. J. Cancer     Publication Date:  1999 Mar 
Date Detail:
Created Date:  1999-08-23     Completed Date:  1999-08-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9005373     Medline TA:  Eur J Cancer     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  512-20     Citation Subset:  IM    
Division de Cancerologie Experimentale, Centre de Recherche Pierre Fabre, Castres, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents, Phytogenic / therapeutic use*
Dose-Response Relationship, Drug
Drug Screening Assays, Antitumor
Mice, Nude
Neoplasm Transplantation
Neoplasms / drug therapy*
Transplantation, Heterologous
Vinblastine / analogs & derivatives*,  therapeutic use
Reg. No./Substance:
0/Antineoplastic Agents, Phytogenic; 162652-95-1/vinflunine; 71486-22-1/vinorelbine; 865-21-4/Vinblastine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ginsenoside-Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevat...
Next Document:  A review of multiple chemical sensitivity.